Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Gains from Sales and Divestitures: 2012-2024

  • Alkermes' Gains from Sales and Divestitures fell 13.73% to $2.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.2 million, marking a year-over-year decrease of 13.73%. This contributed to the annual value of $2.2 million for FY2024, which is 13.73% down from last year.
  • According to the latest figures from Q4 2024, Alkermes' Gains from Sales and Divestitures is $2.2 million, which was down 13.73% from $2.6 million recorded in Q4 2023.
  • Over the past 5 years, Alkermes' Gains from Sales and Divestitures peaked at $2.6 million during Q4 2023, and registered a low of $1.1 million during Q4 2020.
  • For the 3-year period, Alkermes' Gains from Sales and Divestitures averaged around $2.3 million, with its median value being $2.2 million (2024).
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first spiked by 72.16% in 2021, then declined by 13.73% in 2024.
  • Quarterly analysis of 5 years shows Alkermes' Gains from Sales and Divestitures stood at $1.1 million in 2020, then soared by 72.16% to $1.9 million in 2021, then increased by 8.63% to $2.1 million in 2022, then climbed by 26.39% to $2.6 million in 2023, then dropped by 13.73% to $2.2 million in 2024.
  • Its Gains from Sales and Divestitures was $2.2 million in Q4 2024, compared to $2.6 million in Q4 2023 and $2.1 million in Q4 2022.